(PharmaNewsWire.Com, May 17, 2019 ) According to the new market research report "Fluoroscopy Equipment Market by Product (Fixed Fluoroscopy Equipment (Remote Controlled, Conventional), C-arms), Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular)) and Region - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Don’t miss out on business opportunities in Fluoroscopy Equipment Market.
The growth of this market is majorly driven by factors such as technological advancements in the fluoroscopy systems, growing popularity of multipurpose imaging systems, use of fluoroscopy in pain management, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence.
In the fluoroscopy equipment report, the market is segmented by product, application, and region.
On the basis of product, the global market is segmented into fixed fluoroscopy equipment and C-arms. The fixed fluoroscopy equipment market is further segmented into remote-controlled fluoroscopy systems and conventional fluoroscopy systems. The C-arms segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to the increasing demand for minimally invasive procedures and the advantages offered by C-arms such as ease of use in surgical procedures and lower radiation dose compared to fixed fluoroscopy equipment. The C-arms segment has been further segmented into mobile C-arms and mini C-arms.
Browse and in-depth TOC on " Fluoroscopy Equipment Market "
The market is segmented into diagnostic applications and surgical applications. The surgical application segment is expected to grow at the highest rate during the forecast period primarily due to the increasing use of C-arms in surgical imaging. The surgical application segment is further segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications (urologic surgeries, endobronchial and thoracic surgeries, and maxillofacial surgeries).
The diagnostic applications segment holds the larger share of the market. These applications are further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology).
The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing incidence of overuse sports injuries, rising prevalence of cardiovascular diseases (CVDs) and increasing number of hip and knee replacement surgeries in the country.
The risk of radiation exposure from fluoroscopy procedures is likely to restrain market growth. Fluoroscopy procedures are time-consuming, which greatly increases the radiation that patients are exposed to and the risk of hazards such as radiation-induced injuries to the skin and underlying tissues. Long-term side effects of prolonged radiation exposure can also include cancer.
The major players in this market include Siemens AG (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
